Q/C Technologies (QCLS) insider granted 1,080 RSUs, vested 10/3/2025

Q/C Technologies (QCLS) reported an insider equity grant.

Rhea-AI Filing Summary

Q/C Technologies (QCLS) reported an insider equity grant. Director and Chief Medical Officer Mitchell Glass acquired 1,080 shares of common stock on October 3, 2025 via a grant of restricted stock units that vested immediately.

The filing lists the transaction price as $0, consistent with an RSU award, and shows 1,080 shares beneficially owned directly following the transaction.

Insider Trade Summary

Grant/Award: 1,080 shares

Grant/Award 1 txn

Insider Glass Mitchell

Role Director, Chief Medical Off.

Type	Security	Shares	Price	Value
Grant/Award	Common stock	1,080	$0.00	$0.00

Holdings After Transaction: Common stock — 1,080 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of Restricted Stock Units ("RSUs"). The RSUs vested immediately upon grant on October 3, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did QCLS disclose in this Form 4?

An insider equity grant: 1,080 shares acquired by RSU award that vested on October 3, 2025.

Who is the reporting person for QCLS?

Mitchell Glass, a Director and Chief Medical Officer.

How many QCLS shares were acquired and at what price?

1,080 shares at a listed transaction price of $0, reflecting an RSU grant.

What was the vesting schedule for the RSUs?

The RSUs vested immediately upon grant on October 3, 2025.

How many QCLS shares are owned after the transaction?

Beneficial ownership is 1,080 shares, held directly.

What is the security type reported?

Common stock acquired through a restricted stock unit (RSU) grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/06/2025 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glass Mitchell

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS,

SUITE 249

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Q/C TECHNOLOGIES, INC. [ QCLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Director, Chief Medical Off.

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/03/2025		A		1,080	A	$0(1)	1,080	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs"). The RSUs vested immediately upon grant on October 3, 2025.

	/s/ Mitchell Glass	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.